These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 1826346)
21. BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Adnane J; Gaudray P; Dionne CA; Crumley G; Jaye M; Schlessinger J; Jeanteur P; Birnbaum D; Theillet C Oncogene; 1991 Apr; 6(4):659-63. PubMed ID: 1851551 [TBL] [Abstract][Full Text] [Related]
22. Overexpression and amplification of glutathione S-transferase pi gene in head and neck squamous cell carcinomas. Wang X; Pavelic ZP; Li Y; Gleich L; Gartside PS; Pavelic L; Gluckman JL; Stambrook PJ Clin Cancer Res; 1997 Jan; 3(1):111-4. PubMed ID: 9815545 [TBL] [Abstract][Full Text] [Related]
23. Proto-oncogene amplification and human breast tumor phenotype. Adnane J; Gaudray P; Simon MP; Simony-Lafontaine J; Jeanteur P; Theillet C Oncogene; 1989 Nov; 4(11):1389-95. PubMed ID: 2554239 [TBL] [Abstract][Full Text] [Related]
24. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415 [TBL] [Abstract][Full Text] [Related]
25. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells. Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847 [TBL] [Abstract][Full Text] [Related]
26. Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer. Yoshida MC; Wada M; Satoh H; Yoshida T; Sakamoto H; Miyagawa K; Yokota J; Koda T; Kakinuma M; Sugimura T Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4861-4. PubMed ID: 3290903 [TBL] [Abstract][Full Text] [Related]
27. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. Bringuier PP; Tamimi Y; Schuuring E; Schalken J Oncogene; 1996 Apr; 12(8):1747-53. PubMed ID: 8622895 [TBL] [Abstract][Full Text] [Related]
28. c-erbB-2 amplification in node-negative human breast cancer. Ro JS; el-Naggar A; Ro JY; Blick M; Frye D; Fraschini G; Fritsche H; Hortobagyi G Cancer Res; 1989 Dec; 49(24 Pt 1):6941-4. PubMed ID: 2573424 [TBL] [Abstract][Full Text] [Related]
29. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer. Champème MH; Bièche I; Hacène K; Lidereau R Mod Pathol; 1994 Dec; 7(9):900-5. PubMed ID: 7892157 [TBL] [Abstract][Full Text] [Related]
30. Molecular biology of the hst-1 gene. Sugimura T; Yoshida T; Sakamoto H; Katoh O; Hattori Y; Terada M Ciba Found Symp; 1990; 150():79-89; discussion 89-98. PubMed ID: 2142645 [TBL] [Abstract][Full Text] [Related]
31. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959 [TBL] [Abstract][Full Text] [Related]
32. Association of hst gene expression with metastatic phenotype in mouse mammary tumors. Murakami A; Tanaka H; Matsuzawa A Cell Growth Differ; 1990 May; 1(5):225-31. PubMed ID: 1964796 [TBL] [Abstract][Full Text] [Related]
33. PPFIA1 and CCND1 are frequently coamplified in breast cancer. Dancau AM; Wuth L; Waschow M; Holst F; Krohn A; Choschzick M; Terracciano L; Politis S; Kurtz S; Lebeau A; Friedrichs K; Wencke K; Monni O; Simon R Genes Chromosomes Cancer; 2010 Jan; 49(1):1-8. PubMed ID: 19787783 [TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Huang J; Tan PH; Thiyagarajan J; Bay BH Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061 [TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical staining and Southern blot hybridization for glutathione S-transferase pi in mammary infiltrating ductal carcinoma. Frierson HF; Gaffey MJ; Meredith SD; Boyd JC; Williams ME Mod Pathol; 1995 Aug; 8(6):643-7. PubMed ID: 8532698 [TBL] [Abstract][Full Text] [Related]
36. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade. Tsuda H; Fukutomi T; Hirohashi S Clin Cancer Res; 1995 Mar; 1(3):261-7. PubMed ID: 9815981 [TBL] [Abstract][Full Text] [Related]
37. Sporadic amplification of the insulin-like growth factor 1 receptor gene in human breast tumors. Berns EM; Klijn JG; van Staveren IL; Portengen H; Foekens JA Cancer Res; 1992 Feb; 52(4):1036-9. PubMed ID: 1310636 [TBL] [Abstract][Full Text] [Related]
38. Detection of DNA damage in transcriptionally active genes by RT-PCR and assessment of repair of cisplatin-induced damage in the glutathione S-transferase-pi gene in human glioblastoma cells. Brandt TY; Ali-Osman F Toxicol Appl Pharmacol; 1997 Mar; 143(1):22-9. PubMed ID: 9073588 [TBL] [Abstract][Full Text] [Related]
39. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Schuuring E; Verhoeven E; van Tinteren H; Peterse JL; Nunnink B; Thunnissen FB; Devilee P; Cornelisse CJ; van de Vijver MJ; Mooi WJ Cancer Res; 1992 Oct; 52(19):5229-34. PubMed ID: 1394126 [TBL] [Abstract][Full Text] [Related]
40. Amplification at chromosome 11q13 in transitional cell tumours of the bladder. Proctor AJ; Coombs LM; Cairns JP; Knowles MA Oncogene; 1991 May; 6(5):789-95. PubMed ID: 2052357 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]